Logo-jnp
J Nephropathol. 2014;3(1): 1-3. doi: 10.12860/jnp.2014.01
PMID: 24644535        PMCID: PMC3956901

Editorial

Nephrotic syndrome; is rituximab the light at the end of the tunnel in the treatment of adult steroid-dependent minimal change disease and focal segmental glomerulosclerosis?

Andreas Kronbichler 1 * , Gert Mayer 1

Cited by CrossRef: